S100A4 promotes angiogenesis and a pro-tumor immune environment, contributing to metastasis through the release of paracrine factors and pro-inflammatory cytokines, whereas S100A8/9, via the RAGE receptor, activates NF-κB and supports tumor cell growth [99,100]. Here, S100A4 is linked to neoplasm.